Dr. Carruth is an Assistant Professor at Geisinger studying the genetic and clinical factors that influence the development and progression of heritable cardiomyopathies. His research integrates genomic sequencing data, electronic health records, and advanced cardiac imaging to understand disease penetrance, variability in clinical outcomes, and opportunities for improved risk prediction.
Dr. Carruth received his PhD in Bioengineering from the University of California, San Diego, and leads a research program focused on genome-first approaches to cardiovascular disease. His NIH-funded work aims to identify modifiers of genetic risk and advance precision medicine strategies to improve the management of inherited heart disease. He is committed to interdisciplinary collaboration and mentoring trainees in translational genomics.
Dr. Van Syoc is a Staff Scientist in the Carruth group at Geisinger. She received her B.S. from Cal Poly San Luis Obispo, M.S. from the University of Wyoming, and Ph.D. and postdoc from Penn State. In the Carruth group, Dr. Van Syoc tackles EHR phenotyping, genotype-phenotype association analyses, and grant and manuscript writing.
Dr. Winters is a Bioinformatics Staff Scientist at Geisinger. She received a B.A. in Biology from Reed College, Ph.D. in Human Genetics from the University of Maryland, Baltimore, and completed a postdoctoral fellowship at The Johns Hopkins University.
Melissa A Kelly, MS, CGC is a lead clinical genomics data scientist and a licensed, certified genetic counselor with a range of clinical, laboratory, and research experience that has centered around cardiovascular genomics, clinical variant interpretation, and genomic variant pipelines for more than 15 years. Her work focuses on the developing and standardizing systematic approaches to use the MyCode genomic and EHR data for research. Additionally, Ms. Kelly is Co-Director of the Geisinger MyCode Genomic Screening and Counseling Program (GSC) leading the MyCode Clinical Variant Pipeline, responsible for the identification and review of variants prior to confirmation and disclosure to MyCode participants, of which cardiovascular conditions are a large proportion.
Ms. Kelly is an Assistant Professor at the Geisinger College of Health Sciences in the Department of Genomic Health and in Cardiology, actively collaborating and bringing her genomics expertise to multiple NIH-funded projects. Her research centers around the role and impact of variant interpretation in cardiovascular disease, in particular using genomics-first approaches with a focus on inherited cardiomyopathies. Through her work she aims to expand our genomic and phenotypic understanding of actionable genetic conditions, specifically inherited cardiovascular diseases, through population genomic screening and research to inform clinical care.
Mr. Nevius is a Research Project Manager I at Geisinger, where he assists in the design, regulatory implementation, and execution of both prospective and retrospective clinical research. His work primarily focuses on vascular, cardiovascular, and clinical genetics.
He earned his bachelor’s degree from the State University of New York at Cobleskill and has been with Geisinger for over a decade. His experience spans both clinical care and clinical research, providing him with a well-rounded perspective on the challenges and opportunities across healthcare settings.
Mr. Nevius is committed to advancing patient-first approaches to healthcare, supported by rigorous, science-based research.
Katelyn Young, DO
Tyler Avery, MD
Haleema Nawaz, MD
Aradhya Abrol, MD
Mariyam Hassan, MD
Usman Shah, MD
Joshua Miller (2025)
Favour Nelson, MD (2024-2025)
Maria Qureshi, MD (2021-2024)